Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-randomized, Open-label Study To Evaluate The Pharmacokinetics, Safety And Efficacy Of Refacto Af In Previously Treated Pediatric Subjects Less Than Twelve Years Of Age With Severe Hemophilia A (Fviii:c <1%).

NCT00914459 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00914459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00914459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-randomized, Open-label Study To Evaluate The Pharmacokinetics, Safety And Efficacy Of Refacto Af In Previously Treated Pediatric Subjects Less Than Twelve Years Of Age With Severe Hemophilia A (Fviii:c <1%).
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2009
Completion date
April 30, 2016
Enrollment
37 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a